Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT06468618
- Status
- Recruiting
Conditions
- Sleep Disturbance
- Stem Cell Transplant Complications
Eligibility Criteria
- Sex
- ALL
- Age
- 9 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- DREAMS Program Video and Care Kit — BEHAVIORALA pediatric, circadian health program comprised of an introductory video to sleep experiences for stem cell transplant recipients, strategies to improve sleep, and a Sleep and Circadian Care Kit which includes ear plugs, a white noise machine, an eye mask, a lightbox, and kit instructions. Actigraph, Fitbit, and tablet will be provided to participant and family.
Study Details
Pediatric patients undergoing stem cell transplant (SCT) are hospitalized for extended periods and are at high risk for sleep disturbances. In order to begin to address the environmental issues that SCT recipients face during inpatient hospitalizations, investigators will conduct a single arm pilot study of a program entitled 'Developing Restful Environments and Management Strategies' (DREAMS). The program will provide children receiving SCT and families with information and a kit that includes tools which may support sleep and circadian health during an inpatient hospitalization.
Key Dates
- Start date
- Aug 6, 2024
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: DREAMS ProgramEnrolled participants and parent(s) will complete: * Baseline visit with survey * Standard of care stem cell infusion * In-clinic visit with introduction to DREAMS program, Sleep and Circadian Care Kit, Actigraph, and Fitbit. * Follow up survey
Primary Outcome Measure
Enrollment Rate [ Time Frame: Screening (Day -30 to -1) ]
Central Contacts
- Lucille Lokko, BA617-632-6221
- Eric Zhou, PhD617-632-6162
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02215 | Eric Zhou, PhD 617-632-6162 |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | Eric Zhou, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPHASE3 · Recruiting · Pierre Fabre Medicament · Duarte, California
- IS-free Treg HaploHCTPHASE1 · Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationRecruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant SurvivorsRecruiting · Massachusetts General Hospital · Coral Gables, Florida